The Patent Lawyer

News

The latest IP news

 

Sign up to our newsletter
AstraZeneca challenges Axelpharm’s cancer drug patent

AstraZeneca challenges Axelpharm’s cancer drug patent

AstraZeneca is a world-renowned pharmaceutical company. It owns many patents in Russia and takes steps to protect them against encroachers. Its medicines are exempt from sanctions because they are mainly used for the life-preserving treatment of cancer. Axelpharm, a...

USPTO issues final rule on Director Review of PTAB decisions

USPTO issues final rule on Director Review of PTAB decisions

On October 1, 2024, the USPTO published a new final rule, Rules Governing Director Review of Patent Trial and Appeal Board (PTAB) Decisions. 89 Fed. Reg. 79,744 (October 1, 2024). The final rule codifies many aspects of the PTAB’s revised interim Director Review...

UK IPO campaign highlights dangers of counterfeit vehicle parts

UK IPO campaign highlights dangers of counterfeit vehicle parts

The campaign focuses on the serious risks these goods pose, warning that ‘Fake Always Breaks’  The UK Intellectual Property Office (UKIPO) has launched a new national awareness campaign warning of the dangers of buying counterfeit vehicle parts The ‘Fake Always...

Welcome to Hangzhou! The AIPPI World Congress 2024

Welcome to Hangzhou! The AIPPI World Congress 2024

AIPPI World Congress 2024 opened its doors in Hangzhou, China, on Saturday, 19 October. All attending were warmly welcomed, and there was general excitement for the next few days of educational sessions, member meetings, and networking. Guoqing ZHANG, Vice Premier of...

Stuff You Should Know About IP podcast: new episode out now!

CTC Legal Media is very excited to announce that, after a long hiatus, the Stuff You Should Know About IP podcast is back with a brand new episode! Hosted by Ray Guarnieri and Thomas J. Colson, episode 50 focuses on eight intellectual property challenges startups must...

USPTO on trial: patent office sued for patent infringement

The US Patent and Trademark Office (USPTO) has been sued for allegedly infringing on six patents it previously granted. The patents involved are two-factor authentication systems belonging to two individual inventors and are now being contested by Factor2 Multimedia....

Pfizer triumphs over AstraZeneca in cancer drug patent dispute

In a landmark ruling, the US District Court for the District of Delaware has ordered AstraZeneca to pay Pfizer $107.5 million in damages for infringing on patents related to the lung cancer drug 'Tagrisso.' This case marks a significant victory for Pfizer in the...

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

The license agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering. Dublin, Ireland, and Rome, Italy, 20 May 2024 — ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in...

UPC referendum in Ireland postponed

UPC referendum in Ireland postponed

The Irish Government has confirmed its decision to defer the date for the referendum for the ratification of the agreement on a Unified Patent Court (UPC), which was due to be held on 7 June 2024 to coincide with the European and Local elections. No alternative date...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

The Patent Lawyer - Logo

Subscribe To Our Newsletter

Would you like to receive our popular weekly news alerts straight to your inbox? Solely patent focused and only sent once a week means you can guarantee there will be something you are interested in reading instead of clogging up your inbox with junk. Sign up now!

You have Successfully Subscribed!